Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CombiMatrix hires new chief medical officer

This article was originally published in Clinica

Executive Summary

Prenatal and pediatric molecular diagnostics specialist CombiMatrix has appointed Dr Weslie Tyson chief medical officer, effective 8 April. He replaces Dr Richard Hockett, who resigned on 19 February for “personal reasons” according to a filing with the US Securities and Exchange Commission (SEC). New CMO Dr Tyson has been a practising pediatric and perinatal pathologist for 24 years, and previously worked for UniPath, a multispecialty pathology group, since 2009.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT101409

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel